2-Month Dosing Of Aflibercept Proves As Effective As 1-Month Dosing Of Ranibizumab For Wet AMD

Wednesday, October 26, 2011

Ocular Surgery News

Trials meant to increase ease of use of anti-VEGF therapy without sacrificing efficacy in treatment of neovascular age-related macular degeneration have proven successful, a physician said here.

Full Story

A patient with phacodonesis and cataract as shown in the photo desires surgery. Which option is the safest method in this situation?
1. Pars plana lensectomy by retinal surgeon and insertion of AC IOL
2. Intracapsular cataract exctraction and insertion of AC IOL
3. Phacoemulsification and insertion of a capsular tension ring (CTR) and PC IOL
4. Phacoemulsification and iris sutured PC IOL
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

2-Month Dosing Of Aflibercept Proves As Effective As 1-Month Dosing Of Ranibizumab For Wet AMD

Comments

Quick Quiz

A patient with phacodonesis and cataract as shown in the photo desires surgery. Which option is the safest method in this situation?

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2